How Do New Vaccine Technologies Address Toxicological Issues?
New vaccine technologies, such as mRNA and viral vector vaccines, have been designed to minimize toxicological risks. mRNA vaccines, like those developed for COVID-19, do not contain live virus components, reducing the risk of infection. They also use lipids and other substances that are naturally metabolized by the body, minimizing long-term toxicological concerns. Viral vector vaccines use harmless viruses to deliver genetic material, which has been shown to have a favorable safety profile.
